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Abstract
Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity and
mortality in both industrialized and developing countries.
Cigarette smoking is the major risk factor for COPD. However, relevant information from the
literature published within the last years, either on general population samples or on workplaces,
indicate that about 15% of all cases of COPD is work-related.
Specific settings and agents are quoted which have been indicated or confirmed as linked to COPD.
Coal miners, hard-rock miners, tunnel workers, concrete-manufacturing workers, nonmining
industrial workers have been shown to be at highest risk for developing COPD.
Further evidence that occupational agents are capable of inducing COPD comes from experimental
studies, particularly in animal models.
In conclusion, occupational exposure to dusts, chemicals, gases should be considered an
established, or supported by good evidence, risk factor for developing COPD. The implications of
this substantial occupational contribution to COPD must be considered in research planning, in
public policy decision-making, and in clinical practice.
1. Definition
2. Occupational exposures and COPD: epidemiologic evi-
dence
3. Occupational exposures and COPD: experimental evi-
dence
4. Occupationally-related COPD: diagnosis
5. Occupationally-related COPD: management and pre-
vention
1. Definition
Chronic obstructive pulmonary disease (COPD) is a dis-
ease state characterized by airflow limitation that is not
fully reversible. The airflow limitation is usually both pro-
gressive and associated with an abnormal inflammatory
response of the lungs to noxious particles and gases [1].
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Many previous definitions of COPD have emphasized the
terms "emphysema" and "chronic bronchitis" which are
no longer included in the definition of COPD [1]. Emphy-
sema, or destruction of the gas-exchanging surface of the
lung (alveoli), is a pathological term that is often (but
incorrectly) used clinically and describes only one of sev-
eral structural abnormalities present in patients with
COPD. Chronic bronchitis, or the presence of cough and
sputum production for at least 3 months in each of two
consecutive years, remains a clinically and epidemiologi-
cally useful term. However, it does not reflect the major
impact of airflow limitation on morbidity and mortality
in COPD patients. It is also important to recognize that
cough and sputum production may precede the develop-
ment of airflow limitation; conversely, some patients
develop airflow limitation without chronic cough and
sputum production.
COPD does not have a clinical subcategory that is clearly
identified as occupational, largely because the condition
develops slowly and, given that the airflow limitation is
chronic, does not reverse when exposure is discontinued.
Thus, a clinical diagnosis of occupational COPD, using
methods similar to those employed for occupational
asthma, is not feasible. Epidemiologically, the identifica-
tion of occupational COPD is based on observing excess
occurrence of COPD among exposed workers [2-4].
Some work-related obstructive airway disorders have been
classified as COPD but do not neatly fit into this category.
For example, work-related variable airflow limitation may
occur with occupational exposure to organic dusts such as
cotton, flax, hemp, jute, sisal, and various grains. Such
organic dust-induced airway disease is sometimes classi-
fied as an asthma-like disorder [5], but both chronic bron-
chitis and poorly reversible airflow limitation can develop
with chronic exposure. Bronchiolitis obliterans and irri-
tant-induced asthma are two other conditions that may
overlap clinically with work-related COPD.
2. Occupational exposures and COPD: 
epidemiologic evidence
COPD is a major cause of chronic morbidity and mortal-
ity throughout the world. Many people suffer from this
disease for years and die prematurely from it or its compli-
cations. COPD is currently the fourth leading cause of
death in the world [6], and further increases in its preva-
lence and mortality can be predicted in the coming dec-
ades [7].
Cigarette smoking is undoubtedly the main cause of
COPD in the population. A dose-response relationship
between the amount smoked and an observed accelerated
decline in ventilatory function have been consistently
found in longitudinal epidemiological studies [1,8-11];
however, there is a huge individual variation. Fletcher and
Peto [12], in an 8-yr prospective study of working men in
West London, showed that the average decline in FEV1 in
smokers is faster (60 ml/yr) than in non-smokers (30 ml/
yr). However, smokers who develop COPD have an aver-
age decline in FEV1 of greater than 60 ml/yr, and only 15
to 20% of smokers develop clinically significant COPD. In
addition, an estimated 6% of persons who had COPD in
the United States are never smokers [13]. Cigarette smoke
is analogous to a mixed inhalation exposure at a work-
place because it is a complex mixture of particles and
gases.
Despite the difficulty of disentangling the effect of ciga-
rette smoke from those of other exposures, there is grow-
ing evidence from large population based studies
suggesting that a sizeable proportion of the cases of COPD
in a society may be attributable to workplace exposures to
dusts, noxious gases/vapours, and fumes (DGVFs). The
fraction of cases in a population that arise because of cer-
tain exposures is called the attributable fraction in the
population or the population attributable risk (PAR). The
American Thoracic Society (ATS) recently produced a con-
sensus statement based on an evaluation of a number of
large scale general population studies, and calculated that
PAR for COPD was about 15% [14]. Several recent papers
published since the completion of the ATS statement pro-
vide further evidence in support of a major contribution
of occupational exposure to the burden of COPD. Hnizdo
and coworkers from the National Institute for Occupa-
tional Safety and Health used data collected in the US
population-based Third National Health and Nutrition
Examination Survey on more than 9800 subjects to esti-
mate the PAR for COPD attributable to work [15]. The
analysis was adjusted for multiple factors, including
smoking history. The industries with increased risk
include rubber, plastics, and leather manufacturing, utili-
ties, building services, textile manufacturing, and con-
struction. The PAR for COPD attributable to work was
estimated at 19% overall and 31% among never smokers.
A second US population-based study conducted by Trupin
and coworkers [16] obtained survey information on more
than 2000 subjects. Occupational exposures were associ-
ated with increased risk of COPD after adjustment for
smoking history and demographic variables. The PAR for
COPD caused by these exposures was 20%. In this study,
the PAR for combined current and former smokers was
56%. Smoking and occupational exposures to dusts,
gases, and/or fumes had greater than additive effects. A
third study from Sweden was designed to determine
whether occupational exposure to dust, fumes, or gases,
especially among never-smokers, increased the mortality
from COPD [17]. A cohort of more than 317000 Swedish
male construction workers was followed from 1971 to
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chemicals, fumes, and wood dusts was based on a job-
exposure matrix. An internal control group with "unex-
posed" construction workers was used, and the analyses
were adjusted for age and smoking. There was a statisti-
cally significant increase mortality from COPD among
those with any airborne exposure (relative risk 1.12). In a
Poisson regression model, including smoking, age and the
four major exposure groups listed previously, exposure to
inorganic dust was associated with an increased risk, espe-
cially among never-smokers. The fraction of COPD
among the exposed attributable to any airborne exposure
was estimated as 10.7% overall and 52.6% among never-
smokers. Thus, occupational exposure among construc-
tion workers increases mortality due to chronic obstruc-
tive pulmonary disease, even among never-smokers.
The determination of the PAR% due to occupational
exposure has been complicated until recently by the lack
of standardization of definition for COPD. Moreover, rel-
atively few studies have been conducted with the specific
purpose of determining the occupational contribution to
COPD in the general population. In the studies that have
been performed, there has been no consistency in terms of
a strict definition of COPD. Some have presented data on
symptoms and diseases, others have presented data on
lung function, and a few have done both. Although a cer-
tain degree of standardization has been accomplished for
cough and phlegm, dyspnea has been defined more vari-
ably among the studies.
While cigarette smoking and occupational exposures
appear to account in combination for the major propor-
tion of the population attributable risk of COPD, other
influences are potentially important. The understanding
of genetic susceptibility to this condition is still in its rel-
ative infancy, but certain data do suggest that genetics
influences may be important [18], when considering both
the established disease and the accelerated annual decline
in FEV1. Furthermore, interactions have been noted
between  α1  anti-trypsin deficiency and environmental
exposures in the development of COPD [19].
3. Occupational exposures and COPD: 
experimental evidence
The airflow limitation that defines COPD is associated
with lesions that obstruct the small conducting airways,
produce emphysematous destruction of the lung's elastic
recoil force with closure of small airways, or both [20].
Experimental studies have demonstrated that several
agents, including sulphur dioxide, mineral dusts, vana-
dium and endotoxin, are capable of inducing chronic
obstructive bronchitis in animal models [21-24]. The list
of agents that can cause emphysema in animals includes
several for which there is also epidemiological evidence in
exposed occupational cohorts, such as cadmium, coal,
endotoxin, and silica [25]. The clearest human model of
emphysema is that of α1 anti-trypsin deficiency [protease
inhibitor phenotype Z (PI*Z)] [26]. This phenotype
affects only a small percentage of the general population
and is responsible for a correspondingly small fraction of
the total burden of COPD. Although smoking is the most
potent and well-established cofactor in emphysema
related to α1 anti-trypsin deficiency, occupational expo-
sure are linked to such disease as well [27,28].
Because  α1 anti-trypsin is the endogenous inhibitor of
neutrophil elastase and neutrophil elastase is capable to
cause alveolar destruction, it has long been considered the
major player in the development of emphysema. Yet,
despite these evidences, it has been difficult to convinc-
ingly establish a role for neutrophil elastase in emphy-
sema. The association of neutrophil elastase with human
emphysema has been inconsistent, the extracellular
release of neutrophil elastase has been questioned, and
other proteinases have been shown to play a role in exper-
imental models of emphysema. The finding that a murine
knockout model lacking macrophage metalloelastase
(MME) is resistant to the development of cigarette smoke-
induced emphysema has created great interest in this
enzyme and in the potential importance of other pro-
teases [29-31].
The occupationally relevant agents that can cause emphy-
sema (cadmium, coal, endotoxin, and silica), all cause the
centrilobular form of the disease rather than the panaci-
nar form that is associated with α1 anti-trypsin deficiency
so mechanisms other than uninhibited neutrophil
elastase activity are likely operative. The recent evidence
about MME suggests a potential mechanism by which
inhaled dusts or fumes could cause emphysema since
macrophages have a primary role in the clearance of these
materials from the terminal airways and alveoli.
4. Occupationally-related COPD: diagnosis
Cigarette smoking is by far the predominant risk factor for
COPD. Till today, diagnostic assessments able to calculate
the relative contribution of work exposures in a smoker
with COPD are not available. However, adjustment of
associations between occupational exposure and COPD
for smoking status has been performed in epidemiologi-
cal studies, showing that occupational risks likely play a
role on their own. Thus, physicians must be aware of the
potential occupational aetiologies for obstructive airway
disease and should consider them in every patient with
COPD. An occupational history should be the first step in
the initial evaluation of the patient. A proper occupational
history consists of a chronological list of all jobs, includ-
ing job title, a description of the job activities, potential
toxins at each job, and an assessment of the extent and
duration of exposure. The length of time exposed to theJournal of Occupational Medicine and Toxicology 2006, 1:11 http://www.occup-med.com/content/1/1/11
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agent, the use of personal protective equipment such as
respirators, and a description of the ventilation and over-
all hygiene of the workplace are helpful in attempting to
quantify exposure from the patient's history.
Additional information can be obtained from a visit to the
workplace by experts in occupational hygiene, from mate-
rial safety data sheets for workplace chemicals, and from
the manufacturers of the workplace substances.
Identifying occupational risk factors on the individual
level is important for prevention of disease before it is
advanced and for modifying disability risk once disease is
established [32]. In addition, the clinician has a critical
role in case identification for the purposes of public
health surveillance and appropriate work-related insur-
ance compensation.
6. Occupationally-related COPD: management 
and prevention
Directions about the management and prevention of
work-related diseases [33-35], can be applied to COPD as
well. Physicians should attempt to understand the
patient's occupational exposure and whether he/she has
been adequately trained in the dangers of these exposures
and how to manage them. Removal of the respiratory irri-
tants and substitution of non-toxic agents are the best
approach because they eliminate the work-related COPD
hazard. If substitution is not possible, ongoing mainte-
nance of engineering controls, such as enclosure of the
industrial process and improving work area ventilation,
are useful. Administrative controls (e.g., transfer to
another job or change in work practices), and personal
protective equipment (e.g., masks or respirators) should
be mentioned, although less effective in decreasing expo-
sures to respiratory tract irritants.
Guidelines for identification and management of individ-
uals with work-related asthma have been recently pub-
lished [36] and are relevant to work-related COPD. Unlike
workers with sensitizer-induced asthma, workers with irri-
tant-induced asthma or COPD may continue to work in
their usual jobs if their exposure to the inciting agent is
diminished via proper engineering controls or respiratory
protective equipment if engineering controls are not feasi-
ble.
Prevention must be the primary tool for decreasing the
incidence of morbidity and disability from work-related
COPD, which can become severely disabling disease.
Primary prevention is designed to abate hazards before
any damage or injury has occurred. Primary prevention
strategies encompass the same exposure controls (elimi-
nation, engineering controls, administrative controls, per-
sonal protective equipment) described for management
of work-related asthma and COPD due to irritant expo-
sure. As cigarette smoking is the main risk factor for
COPD, we wish to stress that smoking should be discour-
aged outside the workplace as well as inside the work-
place.
Secondary prevention addresses early detection of the dis-
ease so that its duration and severity can be minimized.
Medical surveillance programs are a type of secondary pre-
vention. For medical surveillance of COPD, short symp-
tom questionnaires can be administered before
employment and repeated annually. They should include
items such as improvement in respiratory symptoms on
week-ends and holidays [37-39]. In addition, spirometry
can be performed on an annual basis and compared to
baseline spirometric testing at the time of hire. Review of
peak expiratory flow rate records over several weeks can
also detect workers at risk for developing irritant-induced
COPD.
Tertiary prevention aims at the prevention of permanent
COPD. It includes institution of appropriate health care.
Furthermore, early recognition of the disease and early
removal from, or reduction of, exposure, make it more
likely that the patient will avoid permanent COPD.
Public policy needs to be better informed about the roles
of occupational factors in obstructive airway disease. This
will require active education and outreach on the part of
the medical-scientific community. Specific public policy
issues to be re-examined in light of the magnitude of the
occupational contribution to the burden of airway disease
include standard setting for exposure in and out of the
workplace, attribution criteria for compensation, health
care costs and their assignment, and health care resources
allocation.
The clinician must be aware of the potential occupational
aetiologies for obstructive airway disease and consider
them in every patients with asthma or COPD. Identifying
occupational risk factors on the individual level is impor-
tant for prevention of disease before it is advanced and for
modifying disability risk once disease is established [32].
In addition, the clinician has a critical role in case identi-
fication for the purposes of public health surveillance and
appropriate work-related insurance compensation.
Conclusion
Careful review of the literature demonstrated that approx-
imately 15% of COPD is work-related and that new agents
causing COPD, as well as new cases with persistent airflow
limitation associated with work, are still being reported. It
definitely supports the concept that in a new classification
of risk factors for COPD, occupational exposure to dusts,Journal of Occupational Medicine and Toxicology 2006, 1:11 http://www.occup-med.com/content/1/1/11
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chemicals, gases should be considered an established, or
supported by good evidence, risk factor.
Besides epidemiological studies, further experimental
studies can lead to a better understanding of the occupa-
tional hazards which may cause COPD and establish a
stronger link between the severity of COPD and specific
occupations. Experimental studies may actually serve as
models from which to derive basic insights of COPD and
to identify a cellular basis of the work-related disease.
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